{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:22:25Z","timestamp":1775114545941,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/jp.2016.203","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T14:24:36Z","timestamp":1478787876000},"page":"291-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant tissue plasminogen activator to restore catheter patency: efficacy and safety analysis from a multihospital NICU system"],"prefix":"10.1038","volume":"37","author":[{"given":"D M","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Y","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B C","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V L","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Gerday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"issue":"3","key":"BFjp2016203_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neurol.2015.10.002","volume":"172","author":"M H\u00e9bert","year":"2016","unstructured":"H\u00e9bert M, Lesept F, Vivien D, Macrez R . The story of an exceptional serine protease, tissue-type plasminogen activator (tPA). Rev Neurol (Paris) 2016; 172 (3): 186\u2013197.","journal-title":"Rev Neurol (Paris)"},{"key":"BFjp2016203_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2015.11.020","volume":"171","author":"DA Ansah","year":"2016","unstructured":"Ansah DA, Patel KN, Montegna L, Nicholson GT, Ehrlich AC, Petit CJ . Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. J Pediatr 2016; 171: 67\u201372.e2.","journal-title":"J Pediatr"},{"issue":"1","key":"BFjp2016203_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1188\/08.CJON.155-157","volume":"12","author":"LH Smith","year":"2008","unstructured":"Smith LH . Alteplase for the management of occluded central venous access devices: safety considerations. Clin J Oncol Nurs 2008; 12 (1): 155\u2013157.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"BFjp2016203_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ana.21750","volume":"66","author":"JA Zivin","year":"2009","unstructured":"Zivin JA . Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol 2009; 66 (1): 6\u201310.","journal-title":"Ann Neurol"},{"issue":"8","key":"BFjp2016203_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/archinte.162.8.871","volume":"162","author":"Raad II","year":"2002","unstructured":"Raad II, Hanna HA . Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 2002; 162 (8): 871\u2013878.","journal-title":"Arch Intern Med"},{"key":"BFjp2016203_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1097\/01.RVI.0000241542.71063.83","volume":"17","author":"M Blaney","year":"2006","unstructured":"Blaney M, Shen V, Kerner JA, Jacobs BR, Gray S, Armfield J et al. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study). J Vasc Interv Radiol 2006; 17: 1745\u20131751.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"BFjp2016203_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/pbc.21095","volume":"50","author":"AL Dunn","year":"2008","unstructured":"Dunn AL, Abshire TC . Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy. Pediatr Blood Cancer 2008; 50 (3): 627\u2013629.","journal-title":"Pediatr Blood Cancer"},{"key":"BFjp2016203_CR8","first-page":"405","volume":"47","author":"D Anderson","year":"2013","unstructured":"Anderson D, Pesaturo K, Casavant J, Ramsey E . Alteplase for the treatment of catheter occlusion in pediatric patients. Ann Pharm 2013; 47: 405\u2013410.","journal-title":"Ann Pharm"},{"key":"BFjp2016203_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00001503-200306000-00009","volume":"16","author":"N Haas","year":"2003","unstructured":"Haas N, Haas S . Central venous catheter techniques in infants and children. Curr Opin Anaesthesiol 2003; 16: 291\u2013303.","journal-title":"Curr Opin Anaesthesiol"},{"key":"BFjp2016203_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1067\/mpd.2001.118195","volume":"139","author":"B Jacobs","year":"2001","unstructured":"Jacobs B, Haygood M, Hingl J . Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001; 139: 593\u2013596.","journal-title":"J Pediatr"},{"key":"BFjp2016203_CR11","first-page":"272","volume":"36","author":"E Lee","year":"2002","unstructured":"Lee E . Alteplase use for prevention of central line occlusion in a preterm infant. Ann Pharm 2002; 36: 272\u2013274.","journal-title":"Ann Pharm"},{"issue":"2","key":"BFjp2016203_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jpeds.2009.09.007","volume":"156","author":"H Soylu","year":"2009","unstructured":"Soylu H, Brandao L, Lee K . Efficacy of local instillation of recombinant tissue plasminogen activator for restorting occluded central venous catheters in neonates. J Pediatr 2009; 156 (2): 197\u2013201.","journal-title":"J Pediatr"},{"issue":"3","key":"BFjp2016203_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-0031-1278294","volume":"17","author":"RP Sharma","year":"2008","unstructured":"Sharma RP, Ree CJ, Ree A . Efficacy and safety of a single 2\u2009mg dose or 4\u2009mg double dose of alteplase for 50 occluded chest ports using a unique instillation technique. Int J Angiol 2008; 17 (3): 125\u2013128.","journal-title":"Int J Angiol"},{"issue":"4","key":"BFjp2016203_CR14","first-page":"237","volume":"11","author":"JA Gilarde","year":"2006","unstructured":"Gilarde JA, Chung AM, Vidal R, Falkos S . Efficacy and economic evaluation of a volume-based cathflo activase protocol versus a fixed-dose alteplase protocol for catheter occlusions in pediatric patients. J Pediatr Pharmacol Ther 2006; 11 (4): 237\u2013244.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"8","key":"BFjp2016203_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/jhm.2208","volume":"9","author":"FR Ernst","year":"2014","unstructured":"Ernst FR, Chen E, Lipkin C, Tayama D, Amin AN . Comparison of hospital length of stay, costs, and readmissions of alteplase versus catheter replacement among patients with occluded central venous catheters. J Hosp Med 2014; 9 (8): 490\u2013496.","journal-title":"J Hosp Med"},{"key":"BFjp2016203_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ajic.2013.11.016","volume":"42","author":"K Thakarar","year":"2014","unstructured":"Thakarar K, Collins M, Kwong L, Sulis C, Korn C, Bhadelia N . The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream infections. Am J Infect Control 2014; 42: 417\u2013420.","journal-title":"Am J Infect Control"},{"key":"BFjp2016203_CR17","unstructured":"CathfloTM Activase\u00ae (Alteplase) [packasge insert]. Genentech, Inc.: South San Francisco, CA, USA, 2001."}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp2016203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2016203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2016203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T15:11:18Z","timestamp":1647616278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp2016203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFjp2016203"],"URL":"https:\/\/doi.org\/10.1038\/jp.2016.203","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,10]]},"assertion":[{"value":"8 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}